- Home
- GCV vs NTRB Comparison
GCV vs NTRB Comparison
Compare GCV & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GCV | NTRB |
|---|---|---|
| Founded | 1988 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.1M | 57.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GCV | NTRB |
|---|---|---|
| Price | $4.21 | $4.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 57.9K | ★ 65.5K |
| Earning Date | 01-01-0001 | 12-11-2025 |
| Dividend Yield | ★ 13.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $3.15 | $3.90 |
| 52 Week High | $4.58 | $11.78 |
Technical Indicators
Market Signals| Indicator | GCV | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 45.81 | 43.35 |
| Support Level | $4.11 | $4.34 |
| Resistance Level | $4.28 | $6.41 |
| Average True Range (ATR) | 0.09 | 0.49 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 50.48 | 9.66 |
Price Performance
Historical ComparisonAbout GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.